Development and Validation of Diagnostic Criteria for IBD Subtypes Including IBD-unclassified in Children: a Multicentre Study From the Pediatric IBD Porto Group of ESPGHAN-Reference-Cited by-同舟云学术

Development and Validation of Diagnostic Criteria for IBD Subtypes Including IBD-unclassified in Children: a Multicentre Study From the Pediatric IBD Porto Group of ESPGHAN

Published:2017-04-18 Issue: Volume: Page:
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:

Author:

Birimberg-Schwartz Liron,Zucker David M.,Akriv Amichay,Cucchiara Salvatore,Cameron Fiona L.,Wilson David C.,Łazowska Iza,Yianni Lambri,Paul Siba Prosad,Romano Claudio,Kolaček Sanja,Buderus Stephan,Pærregaard Anders,Russell Richard K.,Escher Johanna C.,Turner Dan

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/doi/10.1093/ecco-jcc/jjx053/17638778/jjx053.pdf

Reference22 articles.

1. Diagnosis and treatment of indeterminate colitis;Gastroenterol Hepatol,2011

2. Recent advances in clinical practice: a systematic review of isolated colonic Crohn’s disease: the third IBD?;Gut,2017

3. Review article: Indeterminate colitis–definition, diagnosis and management;Aliment Pharmacol Ther,2007

4. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology;Can J Gastroenterol,2005

5. Indeterminate colitis;Tech Coloproctol,2007

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential association between M694V homozygous mutation in familial Mediterranean fever and eosinophilic intestinal inflammation: a pediatric case series;Frontiers in Pediatrics;2024-08-02

2. Person-centred care intervention to promote self-efficacy in patients following a myocardial infarction (P2MIR): a protocol of a qualitative study for cultural adaptation within a Portuguese healthcare context;BMJ Open;2024-06

3. Ustekinumab Offers Long-Term Clinical Remission With Safety in Very Early-Onset Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2024-04-08

4. Clinical features of inflammatory bowel disease unclassified: a case-control study;BMC Gastroenterology;2024-03-13

5. Prevalence of Inflammatory Bowel Disease Unclassified, as Estimated Using the Revised Porto Criteria, among Korean Pediatric Patients with Inflammatory Bowel Disease;Pediatric Gastroenterology, Hepatology & Nutrition;2024